Hostname: page-component-7b7567c8c-p67k6 Total loading time: 0 Render date: 2026-11-19T21:37:09.173Z Has data issue: false hasContentIssue false

Residual ploidy abnormalities after preimplantation genetic testing for aneuploidy

Published online by Cambridge University Press:  09 November 2026

Shota Hatakeyama*
Affiliation:
Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku , Tokyo, Japan
Asako Shirai
Affiliation:
Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku , Tokyo, Japan
Emi Yamashiro
Affiliation:
Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku , Tokyo, Japan
Hideaki Watanabe
Affiliation:
Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku , Tokyo, Japan
Sakura Tabata
Affiliation:
Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku , Tokyo, Japan
Erika Morita
Affiliation:
Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku , Tokyo, Japan
Satomi Takeda
Affiliation:
Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku , Tokyo, Japan
Shiori Asano
Affiliation:
Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku , Tokyo, Japan
Kota Yamamoto
Affiliation:
Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku , Tokyo, Japan
Satoshi Ueno
Affiliation:
Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku , Tokyo, Japan
Koji Nakagawa
Affiliation:
Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku , Tokyo, Japan
Rikikazu Sugiyama
Affiliation:
Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku , Tokyo, Japan
*
Corresponding author: Shota Hatakeyama; Email: s.hata25y@gmail.com
Rights & Permissions [Opens in a new window]

Abstract

Next-generation sequencing (NGS)-based preimplantation genetic testing for aneuploidy (PGT-A) is widely used for embryo selection, but conventional copy number–based analysis may fail to detect whole-genome ploidy abnormalities such as haploidy and triploidy. This retrospective study evaluated the frequency of residual ploidy abnormalities detected by single-nucleotide polymorphism (SNP)-based analysis among embryos reported as euploid or mosaic by NGS-based PGT-A. Between May 2022 and January 2025, 5983 blastocysts underwent NGS-based PGT-A at Sugiyama Clinic. Of these, 1601 embryos reported as euploid or mosaic were subjected to additional SNP-based ploidy analysis. SNP-based results were classified as diploid, haploid, triploid, or uncertain. Among the 1601 embryos analysed, 1550 (96.8%) were classified as diploid, 4 (0.3%) as haploid, 11 (0.7%) as triploid and 36 (2.2%) as uncertain. The overall frequency of whole-genome ploidy abnormalities was 0.9% (15/1601). Among the 11 triploid embryos, 4 were derived from intracytoplasmic sperm injection (ICSI) and 7 from conventional in vitro fertilization. All haploid and triploid embryos derived from ICSI showed second polar body extrusion on retrospective time-lapse review. These findings indicate that a small but measurable proportion of embryos reported as euploid or mosaic by NGS-based PGT-A have whole-genome ploidy abnormalities detectable by SNP-based analysis. SNP-based ploidy assessment may provide complementary information in selected clinical workflows.

Information

Type
Research Article
Copyright
© The Author(s), 2026. Published by Cambridge University Press
Figure 0

Table 1.Baseline characteristics and PGT-A outcomesTable 1 long description.

Figure 1

Table 2.SNP-based ploidy results according to fertilization methodTable 2 long description.

Figure 2

Table 3.Characteristics of embryos classified as haploid or triploid by SNP-based ploidy analysisTable 3 long description.